One to Two Cycles of Consolidation Chemotherapy With Capecitabine After Neoadjuvant Chemoradiotherapy Does Not Benefit Low-Risk Patients With Locally Advanced Middle-Low Rectal Cancer

BACKGROUND AND OBJECTIVE: Organ preservation can enable locally advanced rectal cancer (LARC) patients with clinical complete response (cCR) after neoadjuvant treatment to maintain quality of life. In this study, we aimed to evaluate whether one or two cycles of capecitabine after neoadjuvant chemor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Xueqing, Li, Shuai, Zhang, Yangzi, Geng, Jianhao, Wang, Hongzhi, Zhu, Xianggao, Quan, Jizhong, Li, Yongheng, Cai, Yong, Wang, Weihu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515850/
https://www.ncbi.nlm.nih.gov/pubmed/34660266
http://dx.doi.org/10.3389/fonc.2021.695726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515850/
https://www.ncbi.nlm.nih.gov/pubmed/34660266
http://dx.doi.org/10.3389/fonc.2021.695726

Ejemplares similares